Potent anti-cancer effect of 39-hydroxypterostilbene in human colon xenograft tumors

Tzu Chun Cheng, Ching Shu Lai, Min Ching Chung, Nagabhushanam Kalyanam, Muhammed Majeed, Chi Tang Ho, Yuan Soon Ho, Min Hsiung Pan

研究成果: 雜誌貢獻文章同行評審

39 引文 斯高帕斯(Scopus)


Here we report that 39-hydroxypterostilbene (HPSB), a natural pterostilbene analogue, was more potent than pterostilbene against the growth of human cancer cells (COLO 205, HCT-116, and HT-29) with measured IC50 values of 9.0, 40.2, and 70.9 mM, respectively. We found that HPSB effectively inhibited the growth of human colon cancer cells by inducing apoptosis and autophagy. Autophagy occurred at an early stage and was observed through the formation of acidic vesicular organelles and microtubule-associated protein 1 light chain 3-II production. At the molecular levels, the results from western blot analysis showed that HPSB significantly down-regulated phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinases (MAPKs) signalings including decreased the phosphorylation of mammalian target of rapamycin (mTOR). Significant therapeutic effects were demonstrated in vivo by treating nude mice bearing COLO 205 tumor xenografts with HPSB (10 mg/kg i.p.). These inhibitory effects were accompanied by mechanistic down-regulation of the protein levels of cyclooxygenase-2 (COX-2), matrix metallopeptidase-9 (MMP-9), vascular endothelial growth factor (VEGF), and cyclin D1, as well as by the induction of apoptosis in colon tumors. Our findings suggest that HPSB could serve as a novel promising agent for colon cancer treatment. This is an open-access article free of all copyright.

出版狀態已發佈 - 11月 12 2014

ASJC Scopus subject areas

  • 多學科


深入研究「Potent anti-cancer effect of 39-hydroxypterostilbene in human colon xenograft tumors」主題。共同形成了獨特的指紋。